stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Immutep Limited AdrIMMP
$3.250.31%-0.010

Immutep Limited Adr (IMMP)

Immutep Limited Adr stock is traded at $3.25, with a volume of 76,302. It is down -0.31% in the last 24 hours and up +1.56% over the past month. Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.
Previous Close:
$3.26
Open:
$3.16
24h Volume:
76,302
Relative Volume:
1.51
Market Cap:
$23.95M
Revenue:
$2.67M
Net Income/Loss:
-$54.17M
P/E Ratio:
-
EPS:
-$0.3699
Net Cash Flow:
-$39.34M
1W Performance:
-8.71%
1M Performance:
+1.56%
6M Performance:
-67.11%
1Y Performance:
-90.71%
1-Day Range:
$3.06$3.50
1-Week Range:
$3.06$3.76
52-Week Range:
$2.66$70.60

Immutep Limited Adr Stock (IMMP) Company Profile

Name
Immutep Limited Adr
Phone
-
Address
, NSW, Australia
Employee
51
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
IMMP's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Immutep Limited Adr Stock (IMMP) Financials Data

Similar to IMMP